CO4340737A1 - Acidos 5-vinil-y- 5-etinil-quinolon- y naftiridon carboxili- cos - Google Patents

Acidos 5-vinil-y- 5-etinil-quinolon- y naftiridon carboxili- cos

Info

Publication number
CO4340737A1
CO4340737A1 CO95008716A CO95008716A CO4340737A1 CO 4340737 A1 CO4340737 A1 CO 4340737A1 CO 95008716 A CO95008716 A CO 95008716A CO 95008716 A CO95008716 A CO 95008716A CO 4340737 A1 CO4340737 A1 CO 4340737A1
Authority
CO
Colombia
Prior art keywords
methyl
atoms
represents hydrogen
halogen
given
Prior art date
Application number
CO95008716A
Other languages
English (en)
Inventor
Thomas Himmler
Uwe Petersen
Michael Stegemann
Klaus-Dieter Bremm
Rainer Endermann
Heinz-Georg Wetzstein
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CO4340737A1 publication Critical patent/CO4340737A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3526—Organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3544—Organic compounds containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Quinoline Compounds (AREA)

Abstract

1. DERIVADOS DE ACIDOS QUINOLON- Y NAFTIRIDON- CARBOXILICOS, DE FORMULA (I) EN LA CUAL R1 REPRESENTA ALQUILO C1-C4, LINEAL O RAMIFICADO EL CASO SUSTITUIDO POR HIDROXILO, HALOGENO O AL- COXI C1-C3, CICLOALQUILO C3-C6, DADO EL CASO SUS- TITUIDO POR HALOGENO O POR ALQUILO C1-C3, ALQUE- NILO C2-C4, ADEMAS ALCOXI C1-C3, AMINO, MONOAL- QUILAMINO CON 1 A 3 ATOMOS DE C, DIALQUILAMINO CON 2 A 6 ATOMOS DE C O FENILO, DADO EL CASO MONO- A TRISUSTITUIDO POR HALOGENO, R2 REPRESENTA HIDROGENO, ALQUILO CON 1 A 4 ATOMOS (5-METIL-2-OXO-1,3-DIOXOL-4-IL)METILO, X REPRESENTA UN AGRUPAMIENTO CH, C-HALOGENO. COCH3, COCHF2, C-CH3 o N, Z REPRESENTA FIGURA 1 EN DONDE R3 SIGNIFICA HIDROGENO, ALQUILO C1-C3, ALCOXI C1- C3 O ALCOXIMETILO CON 1 A 3 ATOMOS DE C EN LA PAR- TE ALCOXI, R4 SIGNIFICA HIDROGENO O HALOGENO, Y R5 SIGNIFICA HIDROGENO, ALQUILO C1-C6, DADO EL CASO MONO- A TRISUSTITUIDO POR HALOGENO O HIDROXILO, ALQUENILO C2-C3, ALCOXI CON 1 A 3 ATOMOS DE C, ALCOXIMETILO CON 1 A 3 ATOMOS DE C EN LA PARTE ALCOXI, HALOGENO O TRIMETILSILILO, E Y REPRESENTA EN DONDE R6 REPRESENTA HIDROGENO, ALQUILO C1-C4 LINEAL O RAMIFICADO. DADO EL CASO SUSTITUIDO POR HIDROXILO O METOXI, CICLOPROPILO, OXIALQUILO CON 1 A 4 ATOMOS DE C, ACILO CON 1 A 3 ATOMOS DE C, R7 REPRESENTA HIDROGENO, METILO, FENILO, TIENILO O PIRIDILO, R8 REPRESENTA HIDROGENO O METILO, R9 REPRESENTA HIDROGENO O METILO, R10 REPRESENTA HIDROGENO O METILO, R11 REPRESENTA HIDROGENO, METILO o FIGURA 2 R12 REPRESENTA HIDROGENO, METILO, AMINO, ALQUIL- O DIALQUIL-AMINO, DADO EL CASO SUSTITUIDO POR HI- DROXILO, CON 1 O 2 ATOMOS DE C EN LA PARTE ALQUI- LO, AMINOMETILO, AMINOETILO, ALQUIL- O DIALQUIL- AMINOMETILO, DADO EL CASO SUSTITUIDO POR HIDROXI- LO, CON 1 O 2 ATOMOS DE C EN LA PARTE ALQUILO O 1-IMIDAZOLILO, R13 REPRESENTA HIDROGENO, HIDROXILO, METOXI, ME- TILTIO O HALOGENO, METILO, HIDROXIMETILO, R14 REPRESENTA HIDROGENO O METILO, R15 REPRESENTA HIDROGENO, METILO O ETILO, R16 REPRESENTA HIDROGENO, METILO O ETILO, R17 REPRESENTA HIDROGENO, METILO O ETILO, FIGURA 3 R19 REPRESENTA HIDROGENO, ALQUILO C1-C3, DADO EL CASO SUSTITUIDO POR HIDROXILO, ALCOXICARBONILO CON 1 A 4 ATOMOS DE CARBONO EN LA PARTE ALCOXI O ACILO C1-C3, FIGURA 4 FIGURA 5 R21 SIGNIFICA HIDROGENO O METILO, A REPRESENTA CH2, O o UNA UNION DIRECTA, Y n REPRESENTA 1 o 2, Y SUS HIDRATOS Y SALES DE ADICION DE ACIDO UTILI- ZABLES FARMACEUTICAMENTE, ASI COMO LAS SALES AL- CALINAS, ALCALINOTERREAS, ARGENTICAS Y DE GUANIDI- NIO.
CO95008716A 1994-03-11 1995-03-06 Acidos 5-vinil-y- 5-etinil-quinolon- y naftiridon carboxili- cos CO4340737A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4408212A DE4408212A1 (de) 1994-03-11 1994-03-11 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren

Publications (1)

Publication Number Publication Date
CO4340737A1 true CO4340737A1 (es) 1996-07-30

Family

ID=6512492

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95008716A CO4340737A1 (es) 1994-03-11 1995-03-06 Acidos 5-vinil-y- 5-etinil-quinolon- y naftiridon carboxili- cos

Country Status (29)

Country Link
US (2) US5578604A (es)
EP (1) EP0671391A1 (es)
JP (1) JPH07285941A (es)
KR (1) KR950032177A (es)
CN (1) CN1111629A (es)
AU (1) AU689189B2 (es)
BG (1) BG62001B1 (es)
CA (1) CA2144231A1 (es)
CO (1) CO4340737A1 (es)
CZ (1) CZ63895A3 (es)
DE (1) DE4408212A1 (es)
DZ (1) DZ1862A1 (es)
EE (1) EE9500020A (es)
FI (1) FI951101A (es)
HR (1) HRP950077A2 (es)
HU (1) HUT72071A (es)
IL (1) IL112936A0 (es)
LV (1) LV11469B (es)
MA (1) MA23475A1 (es)
NO (1) NO950936L (es)
NZ (1) NZ270657A (es)
PE (1) PE33895A1 (es)
PL (1) PL307583A1 (es)
RU (1) RU95103433A (es)
SK (1) SK31695A3 (es)
SV (1) SV1995000012A (es)
TN (1) TNSN95017A1 (es)
YU (1) YU15895A (es)
ZA (1) ZA952008B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4427530A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
DE19652219A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
US6984499B2 (en) * 1997-10-02 2006-01-10 Idexx Laboratories, Inc. Method and apparatus for concurrently detecting pathogenic organisms and antimicrobial susceptibility
US6815438B2 (en) 1999-12-14 2004-11-09 Neurosearch A/S Heteroaryl-diazabicycloalkanes
US7175988B2 (en) 2001-02-09 2007-02-13 Human Genome Sciences, Inc. Human G-protein Chemokine Receptor (CCR5) HDGNR10
US20040147505A1 (en) * 2001-06-01 2004-07-29 Dan Peters Novel heteroaryl-diazabicyclo alkanes as cns-modulators
DE60233728D1 (de) * 2001-06-06 2009-10-29 Neurosearch As Kationenleitende gaba-a-rezeptoren und deren verwendung
US7393934B2 (en) 2001-12-21 2008-07-01 Human Genome Sciences, Inc. Human G-protein chemokine receptor (CCR5) HDGNR10
JP4639149B2 (ja) 2003-09-10 2011-02-23 杏林製薬株式会社 ７−（４−置換−３−シクロプロピルアミノメチル−１−ピロリジニル）キノロンカルボン酸誘導体
EP1723178A4 (en) 2004-03-12 2007-12-12 Human Genome Sciences Inc HUMAN G-PROTEIN CHEMOKIN RECEPTOR (CCR5) HDGNR10
WO2008143343A1 (ja) 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
CN103724262B (zh) * 2013-12-10 2016-05-18 广东省第二人民医院 一种氟喹诺酮银化合物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563138A (en) * 1987-04-16 1996-10-08 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
NO885426L (no) * 1987-12-11 1989-06-12 Dainippon Pharmaceutical Co Kinolinderivater, samt fremgangsmaate ved fremstilling derav.
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
FI901201A0 (fi) * 1989-03-13 1990-03-09 Bristol Myers Squibb Co Antibakteriella 5-substituerade 1,4-dihydro-4-oxonaftyridin-3-karboxylatderivat och deras framstaellning.
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
US5252734A (en) * 1989-04-03 1993-10-12 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5140033A (en) * 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
AU661999B2 (en) * 1991-05-28 1995-08-17 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative

Also Published As

Publication number Publication date
LV11469A (lv) 1996-08-20
BG62001B1 (bg) 1998-12-30
LV11469B (en) 1996-12-20
HU9500728D0 (en) 1995-04-28
HRP950077A2 (en) 1997-08-31
JPH07285941A (ja) 1995-10-31
ZA952008B (en) 1995-12-11
EP0671391A1 (de) 1995-09-13
TNSN95017A1 (fr) 1996-02-06
MA23475A1 (fr) 1995-10-01
CA2144231A1 (en) 1995-09-12
IL112936A0 (en) 1995-06-29
PE33895A1 (es) 1995-12-15
FI951101A0 (fi) 1995-03-09
BG99490A (en) 1996-01-31
SK31695A3 (en) 1995-09-13
PL307583A1 (en) 1995-09-18
US5659038A (en) 1997-08-19
SV1995000012A (es) 1995-11-06
AU689189B2 (en) 1998-03-26
RU95103433A (ru) 1997-02-10
CN1111629A (zh) 1995-11-15
DE4408212A1 (de) 1995-09-14
YU15895A (sh) 1998-05-15
CZ63895A3 (en) 1995-11-15
NZ270657A (en) 1997-01-29
US5578604A (en) 1996-11-26
FI951101A (fi) 1995-09-12
KR950032177A (ko) 1995-12-20
HUT72071A (en) 1996-03-28
NO950936L (no) 1995-09-12
AU1364995A (en) 1995-09-21
EE9500020A (et) 1995-12-15
DZ1862A1 (fr) 2002-02-17
NO950936D0 (no) 1995-03-10

Similar Documents

Publication Publication Date Title
CO4340737A1 (es) Acidos 5-vinil-y- 5-etinil-quinolon- y naftiridon carboxili- cos
CO5031241A1 (es) Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos
PE107998A1 (es) Derivados de indazol
FI906053A0 (fi) Pyrimidiininukleosidit ja välituotteet
CO5251440A1 (es) Derivados de heterociclil-fenil-oxazolidin-tiofencarboxamida, su procedimiento de obtencion y medicamentos que los contienen
PE20040907A1 (es) Derivados de anilinopirazol
AR027263A1 (es) Derivados de 1,3-dihidro-2h-indol-2-ona, un procedimiento para su preparacion y las composiciones farmaceuticas que los contienen.
AR016210A1 (es) Derivador de tienilazolilalcoxietanamina y sus sales fisiologicamente aceptables, procedimientos para obtener dichos derivados, sus enantiomeros puros ydichas sales, las composiciones farmaceuticas que los contienen, el empleo de dichos derivados para la preparacion de medicamentos, los compuestosin
PE20010543A1 (es) Derivados de purina como inhibidores de tirosincinasa syk
DE69917237D1 (de) Benzofurylpyron-derivate
AR029343A1 (es) USO DE UN ANTAGONISTA DE NMDA DE BAJA AFINIDAD PARA EL TRATAMIENTO DE LA DEPRESIoN
CR7249A (es) Derivados de diamina, proceso para producir los derivados de diamina, y funguicidas que contienen los derivados de diamina como ingrediente activo
ES2171722T3 (es) Nuevos derivados de la 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion a la preparacion de productos biologicamente activos.
PT1202954E (pt) Novas aminobenzofenonas
ES2095848T3 (es) Nuevos derivados de fosfolipidos y su utilizacion para la preparacion de medicamentos antiviricos.
AR043273A1 (es) Derivados de bifenilo, su uso, un proceso para prepararlos y medicamentos que los contienen.
ES2064057T3 (es) Unos derivados de 2-(aminoalquil)-5-(arilalquil)-1,3-dioxanos, su preparacion y su aplicacion en terapeutica.
CO4970779A1 (es) Derivados del acido aminoetilfenoxiacetico y agentes para reducir el dolor y promover la eliminacion de calculos en urolitiasis
MX9201279A (es) Derivados de 1-fenil-3-aza bi ciclo alquil-imidazolidin-2-onas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR045515A1 (es) Procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables
CO5080758A1 (es) DERIVADOS DE 3-(2-oxo-[1,3´]BIPIRROLODINIL-3-ILIDENMETIL
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
MX9307309A (es) Derivados de pirrolo, su preparacion y su aplicacion en terapeutica.
AR046871A1 (es) Compuestos aromaticos como ligandos activadores de los receptores rars, composiciones farmaceuticas y cosmeticas que los contienen y su uso en dermatologia.
AR002259A1 (es) Derivados de 1-oxo-2-(fenilsulfonilamino)pentilpiperidina, su preparacion, compuestos intermedios y composicion que contiene a dichos derivados.